Bottom line
What is DRLAX's expense ratio?
DRLAX's expense ratio is 1.3%, or about $130 a year on every $10,000 invested. That is more expensive than 76% of real estate funds we track (median 0.95%). This share class also charges a front-end sales load of up to 5.75%, taken from your investment when you buy.
Updated Feb 26, 2026
DRLAX fee table
| Net expense ratio | 1.3% |
|---|---|
| Gross expense ratio | 1.5% |
| Management fee | 0.95% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0.55% |
| Fee waiver / reimbursement | -0.2% |
| Max front-end sales load | 5.75% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Feb 26, 2026
What DRLAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| DRLAX | $700 | $1,003 | $1,329 | $2,246 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.3% expense ratio costs roughly $70,100 in lost growth, versus about $52,800 for the median real estate fund (0.95%).
Cheaper alternatives to DRLAX
These funds have a similar portfolio (by top-holdings overlap) and a lower expense ratio. Savings are per $10,000 invested.
*Difference in ending value of $10,000 after 20 years at a 6% gross annual return, net of each fund's expense ratio.